St. Charles Medical Center – Bend is a hospital in Bend, Oregon, United States. It is the largest hospital in Central Oregon, and a level 2 trauma center. St. Charles medical center [SCMC-B] is owned and operated by St. Charles Health System, Inc., a private, not-for-profit Oregon corporation.

There are 226 beds in Saint Charles Health System.

During the past decade, Saint Charles Health System conducted 157 clinical trials. In the 10-year time frame, 157 clinical trials started and 76 clinical trials were completed, i.e. on average, 48.4% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 58 clinical trials were completed. i.e. 89.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Charles Health System" #1 sponsor was "National Cancer Institute (NCI)" with 90 trials, followed by "SWOG Cancer Research Network" with 38 trials sponsored, "Alliance for Clinical Trials in Oncology" with 33 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "NSABP Foundation Inc" with 15 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Charles Health System" #1 collaborator was "National Cancer Institute (NCI)" with 102 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "Saint Charles Health System" are "Breast Cancer" (13 trials), "Invasive Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Saint Charles Health System" in a lesser frequency.

Most popular intervention types in "Saint Charles Health System" are "Drug" (175 trials), "Other" (115 trials), "Biological" (84 trials), "Procedure" (55 trials) and "Radiation" (24 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (53 trials), "Quality-of-Life Assessment" (47 trials), "Questionnaire Administration" (34 trials), "Computed Tomography" (32 trials) and "Biospecimen Collection" (28 trials). Other intervention names were less common.

The vast majority of trials in "Saint Charles Health System" are 172 trials for "All" genders, 41 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Charles Health System". undefined are not yet recruiting, 59 are recruiting, 94 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Saint Charles Health System, 6 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Charles Health System, 7 "Phase 1" clinical trials were conducted, 101 "Phase 2" clinical trials and 115 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

Saint Charles Health System has several departments that took part in Clinical trials: "St. Charles Cancer Center" - 2 trials